The Maitra Lab winding down the evening at #AACRPan23, and catching up with lab alumni Marta Sans Escofet & Maria (both at Merck, Boston). Our team in Boston represented by: 🇺🇸 🇪🇸 🇮🇹 🇮🇳 🇰🇷 🇯🇵 🇸🇪 🇨🇴 🇪🇬 Fredrik Thege Jimin Min Francesca.Paradiso Back to #PancreaticCancer research in the AM!

The The Nobel Prize this morning for Dr. Katalin Kariko is a remarkable story of perseverance and belief in the power of your science despite the setbacks. I am so thankful for her work. But mostly for not giving up. 🙏🏽 #NobelPrize

Friday evening preprint by Fredrik Thege & colleagues MD Anderson Cancer Center: Metabolic Reprogramming by Mutant GNAS Creates an Actionable Dependency in Intraductal Papillary Mucinous Neoplasms of the Pancreas biorxiv.org/content/10.110… Using multiple orthogonal approaches (genome wide

New paper in Gut Journal from Fredrik Thege & colleagues MD Anderson Cancer Center, just in time for #AACRPan24: Metabolic reprogramming by mutant GNAS creates an actionable dependency in intraductal papillary mucinous neoplasms of the pancreas gut.bmj.com/content/early/…

Read the #GUTOnline paper by Makino et al on "Metabolic reprogramming by mutant GNAS creates an actionable dependency in intraductal papillary mucinous neoplasms of the pancreas" via bit.ly/4d6O8F8 Fredrik Thege Anirban Maitra MD Anderson Cancer Center #IPMN

Fredrik Thege introduces his in vivo CRISPR screening platform to study mechanisms of resistance against KRAS inhibitors. This platform does not only work for #PancreaticCancer! A very handy tool for the whole field. #AACRPan24

KRAS Resistance, Mechanisms, and Therapeutics: Andrew Aguirre, Kenneth P. Olive, Mallika Singh, Fredrik Thege, and Andrew Waters discussed this topic in a plenary session at the AACR Special Conference on Advances in Pancreatic Cancer Research. #AACRpan24

Erica D. Pratt demonstrates the potential of liquid biopsies to get a molecular snapshot of what is currently happening in #PancreaticCancer progression. Bioengineering offers advanced tools to monitor PDAC development over time. #AACRPan24

Our dinner tradition of current & former members of the Maitra Lab continues at #AACRPan24. It was wonderful to catch up with everyone. Thank you AACR Let's Win Pancreatic Cancer 💜 for the two scholar in training awards. Exciting day of science for all of us in #PancreaticCancer research.

Read the #GUTOnline paper by Makino et al on "Metabolic reprogramming by mutant GNAS creates an actionable dependency in intraductal papillary mucinous neoplasms of the pancreas" via bit.ly/4d6O8F8 Fredrik Thege Anirban Maitra MD Anderson Cancer Center #IPMN

Read the #GUTOnline paper by Makino et al on "Metabolic reprogramming by mutant GNAS creates an actionable dependency in intraductal papillary mucinous neoplasms of the pancreas" via bit.ly/4d6O8F8 Fredrik Thege Anirban Maitra MD Anderson Cancer Center #IPMN

Congratulations to Fredrik Thege for receiving the uber competitive Hirshberg Foundation Seed Grant for his #PancreaticCancer research. Dude’s on a roll. Find him at #BMES2024 👇🏽

Thrilled to share our latest study just out in nature 😄A major milestone in our collaboration with ⁦Anirban Maitra⁩ Led by brilliant ⁦⁦⁦Guangsheng Pei⁩ ⁦⁦⁦⁦⁦⁦⁦⁦⁦⁦⁦Jimin Min⁩ ⁦⁦MD Anderson Cancer Center⁩ nature.com/articles/s4158…

MD Anderson researchers generated a comprehensive spatial atlas to map clonal evolution, cancer cell states and tumor microenvironment changes to better understand how pancreatic cancer spreads. Learn more: brnw.ch/21wSaZe #EndCancer

🤠 👉🏽 🗽 news: I will be joining NYU Langone Health on September 1, 2025 as Director of the GI Cancer Center & Associate Director of Translational Research at Perlmutter Cancer Center at NYU Langone Health. I am excited to start the next chapter of the Maitra Lab in NYC & build a strong GI cancer research program.

From Malmö to MD Anderson to Columbus — Fredrik Thege, PhD, is joining #OhioStateSurg this fall! His research on KRAS-targeted therapies and pancreatic cancer models is pushing boundaries in cancer science. Welcome, Dr. Thege! 🎉